Professional
Added to YB: 2024-08-13
Pitch date: 2024-07-01
CAMX.ST [bullish]
Camurus AB (publ)
-18.72%
current return
Author Info
No bio for this author
Company Info
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
Market Cap
SEK 27.9B
Pitch Price
SEK 595.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
27.01
P/E
38.09
EV/Sales
10.72
Sector
Pharmaceuticals
Category
value
Protean Funds Scandinavia AB Portfolio Holding: Camurus AB
CAMX.ST: Buvidal/Brixadi franchise expanding; long-release tech platform w/ potential in multiple fields, esp. acromegaly. Recent main owner sell-down created entry opportunity. Transitioning from single-product to multi-application company. Strong growth potential in pharmaceutical tech space.
Read full article (1 min)